Searched for
PIYUSH NAHAR
Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...- Piyush Goyal sees Rs 6,850 crore investments in MP mega textile park"Farmers and businesses will benefit from this park, which is a result of the double-engine government in the state. Investment of around ₹...
- CVC Capital to acquire 36% stake in cancer chain HCGCVC’s investment is expected to trigger an open offer for an additional 26% of the company.
- CVC Capital set to buy into Cancer chain HCG, to be co-promoterSingapore's Temasek holds a 9.4% stake in the widely held company, while Indgrowth Capital owns 1.2%. Public shareholding is 76.1%, as per ...
- CVC Capital set to buy into at cancer chain HCG, PE group likely to become co-promoterThe company is likely to issue new shares to CVC through a preferential allotment. According to some people in the know, the founder promot...
- India recovery divides stock traders on which sectors to bet onMarket participants often have diverging views on stock investments.
- Treatments that can wait make private hospitals wait for revenueThe impact on revenue for private hospitals is expected to last for the next two quarters, ICICI Direct said in a note. For some hospitals,...
- Tycoon loses $3 billion as India’s mobile war weighs on wealthBirla is the latest mogul to burn his fingers in Indian telecom since Mukesh Ambani’s entry.
- Beaten-down telcos soar on signs price war recedingVodafone Idea has soared by 138 per cent since the close of trading Nov. 14.
- China's war on healthcare costs lures India's biggest drugmakerShanghvi believes market watchers are underestimating the potential in China for India’s largest drugmaker.
- Investors irked by lack of disclosures at Sun PharmaThe lack of disclosures around non-related party transactions to the tune of Rs 2,200 crore has become a sore spot for investors, who are q...
- Indian telcos carry most data in worldThe entry of Jio has proved to be a game changer of sorts with average data consumption sky-rocketing and prices falling by more than half.
- Shadow economy struggles under weight of India's new tax regimeThe leather sector is just one example of how India’s vast informal economy -- which accounts for more than 90% of the workforce -- is stru...
- Indian pharma no longer a growth tonic for FIIsSector worries range from USFDA scrutiny to currency pressures and pipeline woes.
- Taro’s decision to invest in wind power project upsets street; brokerages question the moveBrokerages have questioned this move, asking the company whether such a move is an optimal use of cash, which is to the tune of $1 billion ...
- Jefferies maintains buy call on Sun pharma despite adverse guidanceJefferies said it is positive about Sun Pharma's strong key fundamentals, though its stock plunged 15 per cent today.
- Sun Pharma acquires GSK's opiates business in Australia as part of niche foray strategyThe acquisition will give Sun a product portfolio consisting of poppy-derived opiate raw material — mainly used to make painkillers.
- Indian brands with foreign labels like 'Munich Polo' make name for themselvesIndian brands will try to look and sound foreign to make the most of rising aspirations of foreign-label fascinated Indians.
- Foreign investors doubt India’s export numbersForeign investors are questioning the over 30% export growth figures that India has reported for the past eight months even when its bigges...
- US i-bank Jefferies hires 5 from Credit Suisse in IndiaUS investment bank Jefferies Group Inc has strengthened its capital markets team by hiring five people from Credit Suisse Group.
Load More
